Essex Bio-Technology Ltd is committed to embodying a set of core values and corporate philosophy that drives their business operations. The company values integrity, transparency, and innovation as vital components of their organizational culture. Essex Bio-Technology Ltd strives to uphold integrity by maintaining ethical practices and ensuring accountability in all aspects of their operations. They prioritize transparency, aiming to provide clear and reliable information to their stakeholders. Additionally, the company embraces innovation, constantly seeking advanced solutions and breakthroughs in the biotechnology industry. With these values and corporate philosophy, Essex Bio-Technology Ltd prioritizes sustainable growth, fostering trust, and delivering cutting-edge products and services to meet the needs of their customers.

Essex Bio-Technology Ltd is primarily present in various countries and regions across the globe. The company has a strong presence in the United States, where it is headquartered and operates its core operations. Additionally, Essex Bio-Technology Ltd has established a significant presence in Europe, with a focus on countries such as Germany, France, and the United Kingdom. Furthermore, the company has expanded its operations in Asia, particularly in countries like China and Japan. With its global reach, Essex Bio-Technology Ltd is able to serve and cater to a diverse market, ensuring its prominence and growth in the global biotechnology industry.

Essex Bio-Technology Ltd, a leading company in the biotechnology industry, has achieved several significant milestones. Over the years, the company has made remarkable progress in developing innovative medical solutions and advancing healthcare. Essex Bio-Technology Ltd has successfully conducted extensive research and development, resulting in breakthrough discoveries and the development of cutting-edge biopharmaceutical products. The company has also achieved great success in gaining regulatory approvals for its products, expanding its market reach, and securing strategic partnerships with renowned organizations in the field. Essex Bio-Technology Ltd's commitment to excellence and relentless pursuit of scientific advancements have positioned them as a frontrunner in the biotech industry.

Essex Bio-Technology Ltd is a leading company in the biotechnology industry. Established in [year], the company has a rich history of innovative research and development in the field of biotechnology. With its headquarters in [location], Essex Bio-Technology specializes in developing advanced medical treatments and therapies for various diseases and conditions. Over the years, the company has successfully introduced several groundbreaking products that have positively impacted the healthcare industry. Committed to advancements in the biotech sector, Essex Bio-Technology continually invests in cutting-edge technologies and collaborates with renowned scientists and institutions worldwide. With its strong expertise and dedication to improving patients' lives, Essex Bio-Technology remains a prominent player in the biotech arena.

The main competitors of Essex Bio-Technology Ltd in the market include companies such as XYZ Pharmaceuticals, ABC Biotech, and LMN Health Solutions. These companies are active competitors in the biotechnology sector and offer similar products and services as Essex Bio-Technology Ltd. However, Essex Bio-Technology Ltd stands out with its cutting-edge research and development, strong market presence, and innovative product offerings. As a leading player in the biotechnology industry, Essex Bio-Technology Ltd continually strives to stay ahead of the competition through its commitment to scientific excellence and delivering impactful solutions to its customers.

Essex Bio-Technology Ltd is primarily active in the pharmaceutical and biotechnology industries.

The business model of Essex Bio-Technology Ltd focuses on the development and commercialization of innovative pharmaceutical products. The company is engaged in research, manufacturing, and marketing of biotechnological and healthcare products. Essex Bio-Technology aims to improve the quality of life by providing treatments for various therapeutic areas such as oncology, immunology, and neurology. Through strategic collaborations and cutting-edge technology, the company strives to bring effective and affordable medications to patients worldwide. Essex Bio-Technology's business model prioritizes research and development, ensuring a constant stream of new products and advancements in the healthcare industry.

สัดส่วนราคาต่อกำไรของ Essex Bio-Technology คือ 0

KUV ของ Essex Bio-Technology คือ 0.68

AlleAktien คุณภาพสกอร์สำหรับ Essex Bio-Technology คือ 9/10.

คาดหวัง Essex Bio-Technology มียอดขายอยู่ที่ 2.25 ล้านล้าน HKD

ขณะนี้ไม่สามารถคำนวณกำไรสำหรับ Essex Bio-Technology ได้

Essex Bio-Technology Ltd is an emerging company in the biotechnology industry, specializing in the discovery, development, and marketing of innovative products and services. The company is headquartered in Essex, United Kingdom and operates globally. The main division of Essex Bio-Technology is drug development, including the identification and development of new active substances and pharmaceutical therapies. The company has a wide range of drug candidates in various stages of development, including drugs for cancer, cardiovascular diseases, autoimmune diseases, and infections. Additionally, it also works closely with other companies and research institutions to advance drug development in various areas. Another important division of Essex Bio-Technology is the development of diagnostics, including molecular diagnostics and point-of-care tests. These tests are mainly used for early disease detection and can also be utilized for disease monitoring and the development of personalized therapies. The company also offers a comprehensive range of research services, including custom assays and analysis services, target identification and validation, and screening services. These services help companies accelerate and optimize their research and development programs. Essex Bio-Technology also has a strong presence in the field of agricultural and food sciences. The company develops innovative methods to improve plant and animal health, as well as enhance the productivity and quality of crops and food products. Another important area of Essex Bio-Technology is environmental technology, including the development of biofuels and biodegradable materials. The company is committed to reducing environmental impact through the use of more sustainable materials and technologies. In terms of its products, Essex Bio-Technology offers a wide range of pharmaceuticals, diagnostics, and research services. Key products currently include new drug candidates in various stages of development, as well as diagnostics for the early detection of cancer and other diseases. Essex Bio-Technology is committed to staying innovative and state-of-the-art by continuously investing in research and development. The company also works closely with its network of partners and customers to continuously develop new and innovative products and solutions that meet customer needs. Overall, Essex Bio-Technology's business model is diverse and encompasses drug development, diagnostics, research services, agricultural and food sciences, and environmental technology. The company aims to develop innovative solutions to address global challenges and remains at the forefront of technology by investing in research and development.

Essex Bio-Technology จ่ายเงินปันผล 0.1 HKD ผ่าน ครั้งในหนภายในหนึ่งปี.

ปัจจุบันไม่สามารถคำนวณเงินปันผลสำหรับ Essex Bio-Technology หรือบริษัทไม่จ่ายเงินปันผล.

ISIN ของ Essex Bio-Technology คือ KYG312371035

WKN ของ Essex Bio-Technology คือ 693609.

ตัวย่อของ Essex Bio-Technology คือ 1061.HK

ภายในช่วง 12 เดือนที่ผ่านมา Essex Bio-Technology จ่ายเงินปันผลทั้งหมด 0.07 HKD นี้เทียบเท่ากับอัตราผลตอบแทนจากเงินปันผลประมาณ 2.7 % สำหรับ 12 เดือนข้างหน้า Essex Bio-Technology คาดว่าจะจ่ายเงินปันผลทั้งหมด 0.08 HKD

อัตราผลตอบแทนเงินปันผลของ Essex Bio-Technology ในปัจจุบันคือ 2.7 %

Essex Bio-Technology จ่ายเงินปันผลทุกไตรมาส การจ่ายเงินปันผลจะเกิดขึ้นในเดือน กันยายน, มิถุนายน, ตุลาคม, ตุลาคม

Essex Bio-Technology จ่ายเงินปันผลทุกปีในช่วง 0 ปีที่ผ่านมา.

คาดว่าในช่วง 12 เดือนข้างหน้าจะมีการจ่ายเงินปันผลทั้งหมด 0.08 HKD ซึ่งเทียบเท่ากับผลตอบแทนจากเงินปันผลร้อยละ 2.98 %

Essex Bio-Technology ถูกจัดให้อยู่ในภาคส่วน 'สุขภาพ'

เพื่อรับเงินปันผลล่าสุดของ Essex Bio-Technology ในวันที่ 24/9/2567 ที่มูลค่า 0.06 HKD คุณจะต้องถือหุ้นไว้ในพอร์ตก่อนวันที่เป็น Ex-Tag ในวันที่ 9/9/2567

การจ่ายเงินปันผลครั้งล่าสุดเกิดขึ้นเมื่อวันที่ 24/9/2567

ในปี 2023 บริษัท Essex Bio-Technology ได้จ่ายเงินปันผลเป็นจำนวน 0.095 HKD

เงินปันผลของ Essex Bio-Technology จะถูกจ่ายใน HKD